Trademark: 87693990
Status Date
Monday, February 11, 2019
Filing Date
Tuesday, November 21, 2017
Published for Opposition
Tuesday, May 15, 2018
Abandoned Date
Monday, February 11, 2019
5 House mark for pharmaceutical preparations containing protein, namely, pharmaceutical preparations for use in the treatment of oncological and inflammatory diseases and disorders, and complications associated therewith; protein used as an erythropoiesis stimulant; pharmaceuticals containing protein for stimulating white blood cell production; pharmaceuticals containing protein for treating human immune diseases and conditions; pharmaceutical preparations containing protein for the treatment of multiple sclerosis, lymphoma, leukemia and transplant rejections; pharmaceutical compositions containing protein for treatment of autoimmune diseases and disorders; pharmaceutical preparations containing protein for the treatment of proliferative disorders, namely, angiogenic disorders and cancer; and syringes sold filled with each of the foregoing pharmaceutical preparations containing protein for treatment of the aforementioned diseases and disorders and complications associated therewith
Feb 11, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 11, 2019
Abandonment - No Use Statement Filed
Jul 10, 2018
Noa E-Mailed - Sou Required From Applicant
May 15, 2018
Official Gazette Publication Confirmation E-Mailed
May 15, 2018
Published For Opposition
Apr 25, 2018
Notification Of Notice Of Publication E-Mailed
Apr 9, 2018
Assigned To Lie
Apr 3, 2018
Approved For Pub - Principal Register
Mar 12, 2018
Teas/Email Correspondence Entered
Mar 12, 2018
Correspondence Received In Law Office
Mar 12, 2018
Teas Response To Office Action Received
Mar 12, 2018
Notification Of Non-Final Action E-Mailed
Mar 12, 2018
Non-Final Action E-Mailed
Mar 12, 2018
Non-Final Action Written
Mar 6, 2018
Assigned To Examiner
Dec 4, 2017
New Application Office Supplied Data Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24